Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
KalVista Pharmaceuticals, Inc. (KALV) had Weighted-Average Shares Outstanding (Diluted) of 53.50M for the most recently reported fiscal quarter, ending 2025-07-31.
| Income Statement Financials | |
$1.43M |
|
$-60.10M |
|
$0.59M |
|
$0.84M |
|
$60.44M |
|
$-59.01M |
|
$1.07M |
|
$-57.94M |
|
$-57.94M |
|
$-60.10M |
|
$-60.10M |
|
$-60.10M |
|
$-60.10M |
|
$-59.01M |
|
$-58.76M |
|
53.50M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
53.50M |
$-1.12 |
|
$-1.12 |
|
| Balance Sheet Financials | |
$205.90M |
|
$2.07M |
|
$9.61M |
|
$215.50M |
|
$38.38M |
|
-- |
|
$136.34M |
|
$174.72M |
|
$40.79M |
|
$40.79M |
|
$40.79M |
|
50.34M |
|
| Cash Flow Statement Financials | |
$-54.50M |
|
$21.26M |
|
$23.21M |
|
$132.27M |
|
$124.96M |
|
$-7.31M |
|
$5.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
58.63% |
|
-4138.08% |
|
-4138.08% |
|
-- |
|
-4063.04% |
|
-4214.31% |
|
$-54.94M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.57 |
|
156.96 |
|
-147.33% |
|
-147.33% |
|
-27.89% |
|
-147.33% |
|
$0.81 |
|
$-1.03 |
|
$-1.02 |
|